IgA-nefropátia: vizsgálatok itt: Kanada
5 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
- Where
- Calgary, London, Toronto
- Életkor
- 18 év and over
- People
- 347 worldwide
- Run by
- Takeda
See details and how to joinNCT06963827 · EU 2025-520825-19-00 - 3. fázisTaking peopleA Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
- Where
- Montreal, Vancouver
- Életkor
- 18 év and over
- People
- 454 worldwide
- Run by
- Biogen
See details and how to joinNCT06935357 · EU 2024-519345-30-00 - 3. fázisTaking peopleA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- Where
- Oshawa
- Életkor
- 18 év to 100 év
- People
- 540 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04557462 · EU 2023-508690-92-00 - 3. fázisTaking peopleOpen-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Where
- Toronto
- Életkor
- 18 év to 100 év
- People
- 220 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06858319 - 2/3. fázisCsak meghívásosTrial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)
- Where
- Calgary, Greenfield Park, Scarborough Village
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT05248659